Nano‐formulated drugs in oral carcinomas

Oral SurgeryEarly View LETTER TO THE EDITOR Nano-formulated drugs in oral carcinomas Ankita Mathur, Ankita Mathur Department of Dental Research Cell, Dr. D. Y. Patil Dental College and Hospital, Dr. D. Y. Patil Vidyapeeth, Pune, IndiaSearch for more papers by this authorSnehasish Tripathy, Snehasish Tripathy Department of Dental Research Cell, Dr. D. Y. Patil Dental College and Hospital, Dr. D. Y. Patil Vidyapeeth, Pune, IndiaSearch for more papers by this authorVini Mehta, Corresponding Author Vini Mehta [email protected] orcid.org/0000-0003-4174-907X Department of Dental Research Cell, Dr. D. Y. Patil Dental College and Hospital, Dr. D. Y. Patil Vidyapeeth, Pune, India Correspondence Vini Mehta, Department of Dental Research Cell, Dr. D. Y. Patil Dental College and Hospital, Dr. D. Y. Patil Vidyapeeth, Pimpri, Pune 411018, India. Email: [email protected]Search for more papers by this author Ankita Mathur, Ankita Mathur Department of Dental Research Cell, Dr. D. Y. Patil Dental College and Hospital, Dr. D. Y. Patil Vidyapeeth, Pune, IndiaSearch for more papers by this authorSnehasish Tripathy, Snehasish Tripathy Department of Dental Research Cell, Dr. D. Y. Patil Dental College and Hospital, Dr. D. Y. Patil Vidyapeeth, Pune, IndiaSearch for more papers by this authorVini Mehta, Corresponding Author Vini Mehta [email protected] orcid.org/0000-0003-4174-907X Department of Dental Research Cell, Dr. D. Y. Patil Dental College and Hospital, Dr. D. Y. Patil Vidyapeeth, Pune, India Correspondence Vini Mehta, Department of Dental Research Cell, Dr. D. Y. Patil Dental College and Hospital, Dr. D. Y. Patil Vidyapeeth, Pimpri, Pune 411018, India. Email: [email protected]Search for more papers by this author First published: 22 September 2023 https://doi.org/10.1111/ors.12853Read the full textAboutPDF ToolsRequest permissionExport citationAdd to favoritesTrack citation ShareShare Give accessShare full text accessShare full-text accessPlease review our Terms and Conditions of Use and check box below to share full-text version of article.I have read and accept the Wiley Online Library Terms and Conditions of UseShareable LinkUse the link below to share a full-text version of this article with your friends and colleagues. Learn more.Copy URL Share a linkShare onEmailFacebookTwitterLinkedInRedditWechat No abstract is available for this article. REFERENCES 1Sahu T, Ratre YK, Chauhan S, Bhaskar LVKS, Nair MP, Verma HK. Nanotechnology based drug delivery system: current strategies and emerging therapeutic potential for medical science. J Drug Deliv Sci Technol. 2021; 63:102487. https://doi.org/10.1016/j.jddst.2021.102487 2Zhang Y, Li M, Gao X, Chen Y, Liu T. Nanotechnology in cancer diagnosis: progress, challenges and opportunities. J Hematol Oncol. 2019; 12(1): 137. https://doi.org/10.1186/s13045-019-0833-3 3Oral cancer—the fight must go on against all odds…. Evid Based Dent. 2022; 23(1): 4–5. https://doi.org/10.1038/s41432-022-0243-1 4Nakamura H, Jun F, Maeda H. Development of next-generation macromolecular drugs based on the EPR effect: challenges and pitfalls. Expert Opin Drug Deliv. 2015; 12(1): 53–64. https://doi.org/10.1517/17425247.2014.955011 5Rajora AK, Ravishankar D, Zhang H, Rosenholm JM. Recent advances and impact of chemotherapeutic and antiangiogenic nanoformulations for combination cancer therapy. Pharmaceutics. 2020; 12(6):592. https://doi.org/10.3390/pharmaceutics12060592 6Thambiraj S, Vijayalakshmi R, Ravi SD. An effective strategy for the development of docetaxel encapsulated gold nanoformulations for treatment of prostate cancer. Sci Rep. 2021; 11(1): 2808. https://doi.org/10.1038/s41598-020-80529-1 7Mansour A, Mahmoud MY, Bakr AF, Ghoniem MG, Adam FA, El-Sherbiny IM. Dual-enhanced pluronic nanoformulated methotrexate-based treatment approach for breast cancer: development and evaluation of in vitro and in vivo efficiency. Pharmaceutics. 2022; 14(12):2668. https://doi.org/10.3390/pharmaceutics14122668 8Halawani EM, Hassan AM, Gad El-Rab SMF. Nanoformulation of biogenic cefotaxime-conjugated-silver nanoparticles for enhanced antibacterial efficacy against multidrug-resistant bacteria and anticancer studies. Int J Nanomedicine. 2020; 15: 1889–1901. https://doi.org/10.2147/IJN.S236182 9Siddique S, Chow JCL. Recent advances in functionalized nanoparticles in cancer theranostics. Nanomaterials. 2022; 12(16):2826. https://doi.org/10.3390/nano12162826 10Babu A, Templeton AK, Munshi A, Ramesh R. Nanoparticle-based drug delivery for therapy of lung cancer: Progress and challenges. J Nanomater. 2013; 2013:e863951. https://doi.org/10.1155/2013/863951 11Gavas S, Quazi S, Karpiński TM. Nanoparticles for cancer therapy: current progress and challenges. Nanoscale Res Lett. 2021; 16(1): 173. https://doi.org/10.1186/s11671-021-03628-6 Early ViewOnline Version of Record before inclusion in an issue ReferencesRelatedInformation